6.82
16.01%
-1.30
Handel nachbörslich:
6.81
-0.01
-0.15%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt CAMP?
Forum
Prognose
Aktiensplit
Calamp Corp Aktie (CAMP) Neueste Nachrichten
William Blair Initiates Coverage of Camp4 Therapeutics (CAMP) with Outperform Recommendation - MSN
October IPOs in Biotech, Cleantech, Transportation, Retail and Homebuilder Sectors - Investorideas.com newswire
Camp4 Therapeutics initiated with an Overweight at Piper Sandler - MSN
JP Morgan Initiates Coverage of Camp4 Therapeutics (CAMP) with Overweight Recommendation - MSN
JPMorgan sees "breakthrough potential" in CAMP4 stock, bets big on RNA tech - Investing.com Australia
CAMP4 Analyst Highlights Rare Disease Platform Potential - Benzinga
Camp4 gains after earning bullish views on Street - MSN
Camp4 stock gains after earning bullish views (CAMP:NASDAQ) - Seeking Alpha
William Blair upbeat on CAMP4 shares with Outperform rating - Investing.com
William Blair upbeat on CAMP4 shares with Outperform rating By Investing.com - Investing.com Canada
Leerink sets stock target for CAMP4, cites broad UCD treatment potential - Investing.com India
Piper Sandler optimistic on CAMP4 stock, cites potential in pioneering RNA technology - Investing.com
Finance Watch: Septerna Raises $288m In Public Market Debut - Citeline
Internet of Things (IoT) in Construction Market Worth Over $61.7 Billion by 2030Industry Analysis and Forecast with Profiles of 37 Major Companies Including Autodesk, Calamp Corp, Caterpillar, Dronedeploy - GlobeNewswire
CeriBell Shares Rise 47% to Lead Trio of Life Sciences IPOs - MSN
Warren Buffett and Biotech IPOs Highlight Recent Insider Buying - 24/7 Wall St.
Camp4 Therapeutics sees $8.4 million stock purchase by Northpond Ventures - Investing.com India
Camp4 Therapeutics sees $7.99m stock purchase by investors By Investing.com - Investing.com India
Insider Trading Recap: Thursday's Top Buys and Sells in US Stocks - Investing.com India
CAMP4 Rings the Opening Bell - Nasdaq
Insider Trading Activity Tuesday: Top Buys and Sells in US Stocks Revealed - Investing.com
Camp4 Therapeutics sees $9.99 million stock purchase by Polaris - Investing.com
Camp4 Therapeutics sees $9.99 million stock purchase by 5AM Ventures - Investing.com Australia
Camp4 Therapeutics director Nashat Amir buys $9.99m in stock - Investing.com India
Camp4 Therapeutics director Nashat Amir buys $9.99m in stock By Investing.com - Investing.com Australia
Camp4 Therapeutics director Andrew Schwab buys $9.99m in stock - Investing.com
Camp4 Therapeutics director Andrew Schwab buys $9.99m in stock By Investing.com - Investing.com South Africa
Upstream Bio and Camp4 and Ceribell Transactions - William Blair
CAMP4 Therapeutics’ $75 Million IPO - Global Legal Chronicle
Opening Day: Another trio of biotech IPOs make Friday debut - Yahoo Finance
Upstream Bio Leads Life Sciences IPOs With Upsized Listing - MSN
CAMP4 stock edges up 2% following $75M IPO - MSN
Upstream catches aftermarket updraft, as Camp4 IPO gets muted reception - BioCentury
Finance Watch: 2024 Has Now Beaten 2023’s Total Of 21 IPOs - Scrip
Upstream Bio Shares Rise 26% to Lead Burst of Life Sciences IPOs - MSN
6 Firms Guide IPO Trio From Biotech, Medical Device Cos. - Law360
Form 424B4 Camp4 Therapeutics Corp - StreetInsider.com
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):